About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [3,386 citations: 1–100 of 2,992 articles]

Articles published in International Journal of Alzheimer’s Disease have been cited 3,386 times. The following is a list of the 2,992 articles that have cited the articles published in International Journal of Alzheimer’s Disease.

  • Brian P. Cary, Allen F. Brooks, Maria V. Fawaz, Lindsey R. Drake, Timothy J. Desmond, Phillip Sherman, Carole A. Quesada, and Peter J. H. Scott, “ Synthesis and Evaluation of [ 18 F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts ,” ACS Chemical Neuroscience, 2016. View at Publisher · View at Google Scholar
  • D.V. Moretti, “Involvement of mirror neuron system in prodromal Alzheimer's disease,” BBA Clinical, vol. 5, pp. 46–53, 2016. View at Publisher · View at Google Scholar
  • Christina L. Nemeth, Andrew H. Miller, Malú G. Tansey, and Gretchen N. Neigh, “Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors.,” Behavioural Brain Research, 2016. View at Publisher · View at Google Scholar
  • Susmita Sil, and Tusharkanti Ghosh, “Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease,” Behavioural Neurology, vol. 2016, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Anja Hviid Simonsen, Bea Kuiperij, Omar Mukhtar Ali El-Agnaf, Sebastian Engelborghs, Sanna-Kaisa Herukka, Lucilla Parnetti, Irena Rektorova, Eugeen Vanmechelen, Elisabeth Kapaki, Marcel Verbeek, and Brit Mollenhauer, “The utility of -synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature,” Biomarkers In Medicine, vol. 10, no. 1, pp. 19–34, 2016. View at Publisher · View at Google Scholar
  • Zamira Gibb, and Robert J. Aitken, “ The Impact of Sperm Metabolism during In Vitro Storage: The Stallion as a Model ,” BioMed Research International, vol. 2016, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Christina Loosse, Magdalena Pawlas, Hassan S. S. Bukhari, Abdelouahid Maghnouj, Stephan Hahn, Katrin Marcus, and Thorsten Mueller, “Nuclear spheres modulate the expression of BEST1 and GADD45G,” Cellular Signalling, vol. 28, no. 1, pp. 100–109, 2016. View at Publisher · View at Google Scholar
  • Andreia Cuco, Ana Paula Serro, José Paulo Farinha, Benilde Saramago, and Amélia Gonçalves da Silva, “Interaction of the Alzheimer Aβ(25−35) peptide segment with model membranes,” Colloids and Surfaces B: Biointerfaces, 2016. View at Publisher · View at Google Scholar
  • Paola Piscopo, Diego Albani, Anna E. Castellano, Gianluigi Forloni, and Annamaria Confaloni, “Frontotemporal Lobar Degeneration and MicroRNAs,” Frontiers in Aging Neuroscience, vol. 8, 2016. View at Publisher · View at Google Scholar
  • Bronwen Martin, Wayne Chadwick, Jonathan Janssens, Richard T. Premont, Robert Schmalzigaug, Kevin G. Becker, Elin Lehrmann, William H. Wood, Yongqing Zhang, Sana Siddiqui, Sung-Soo Park, Wei-na Cong, Caitlin M. Daimon, and Stuart Maudsley, “GIT2 Acts as a Systems-Level Coordinator of Neurometabolic Activity and Pathophysiological Aging,” Frontiers in Endocrinology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Jonathan J. Sabbagh, and Chad A. Dickey, “The Metamorphic Nature of the Tau Protein: Dynamic Flexibility Comes at a Cost,” Frontiers in Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Ramon Yarza, Silvia Vela, Maite Solas, and Maria J. Ramirez, “c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease,” Frontiers in Pharmacology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Alaina J. Garrie, Shruti Goel, and Martin M. Forsberg, “Medical Students’ Perceptions of Dementia after Participation in Poetry Workshop with People with Dementia,” International Journal of Alzheimer's Disease, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Somayeh Jahani, Saeide Saeidi, Fereshteh Javadian, Zahra Akbarizadeh, and Ali Sobhanizade, “Investigating the Antibacterial Effects of Plant Extracts on Pseudomonas aeruginosa and Escherichia coli,” International Journal of Infection, vol. 3, no. 2, 2016. View at Publisher · View at Google Scholar
  • Debanjan Tewari, Mohona Mukhopadhyay, Madhav Siva Nekkanti, Sirisha Vallabhaneni, Giriraj Sahu, Suresh Kumar Jetti, D.S. Preethidan, and Amal Kanti Bera, “Cytoprotective effect of Centella asiatica is mediated through the modulation of mitochondrial voltage-dependent anion channel (VDAC) and scavenging of free radicals,” Journal of Functional Foods, vol. 21, pp. 301–311, 2016. View at Publisher · View at Google Scholar
  • Guanglin Luo, Ling Chen, Catherine R Burton, Hong Xiao, Prasanna Sivaprakasam, Carol M Krause, Yang Cao, Nengyi Liu, Jonathan Lippy, Wendy J Clarke, Kimberly Snow, Joseph Raybon, Vinod Arora, Matt Pokross, Kevin Kish, Hal A. Lewis, David R. Langley, John E. Macor, and Gene M. Dubowchik, “Discovery of Isonicotinamides as Highly Selective, Brain Penetrable and Orally Active Glycogen Synthase Kinase-3 Inhibitors,” Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Mehmet Bulut, Aylin Yaman, Muhammet Kazim Erol, Fatma Kurtuluş, Devrim Toslak, Berna Doğan, Deniz Turgut Çoban, and Ebru Kaya Başar, “Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer’s Type Dementia,” Journal of Ophthalmology, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Maneesh Jaiswal, Arun Kumar, and Shivani Sharma, “Nanoemulsions loaded Carbopol® 934 based gel for intranasal delivery of neuroprotective Centella asiatica extract: in–vitro and ex–vivo permeation study,” Journal of Pharmaceutical Investigation, 2016. View at Publisher · View at Google Scholar
  • Anna Tasegian, Francesco Curcio, Laura Dalla Ragione, Francesca Rossetti, Samuela Cataldi, Michela Codini, Francesco Saverio Ambesi-Impiombato, Tommaso Beccari, and Elisabetta Albi, “Hypovitaminosis D3, Leukopenia, and Human Serotonin Transporter Polymorphism in Anorexia Nervosa and Bulimia Nervosa,” Mediators of Inflammation, vol. 2016, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • Toshio Ariga, “The Pathogenic Role of Ganglioside Metabolism in Alzheimer’s Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  • Sukhleen Kour, and Pramod C. Rath, “Age-Related Expression of a Repeat-Rich Intergenic Long Noncoding RNA in the Rat Brain,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  • Gilberto J. Paz-Filho, “The Effects of Leptin Replacement on Neural Plasticity,” Neural Plasticity, vol. 2016, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Xian-Cang Ma, Zheng Chu, Xiao-Ling Zhang, Wen-Hui Jiang, Min Jia, Yong-Hui Dang, and Cheng-Ge Gao, “Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect,” Neurochemical Research, 2016. View at Publisher · View at Google Scholar
  • Ke Zeng, Jiaqing Yan, Yinghua Wang, Attila Sik, Gaoxiang Ouyang, and Xiaoli Li, “Automatic detection of absence seizures with compressive sensing EEG,” Neurocomputing, vol. 171, pp. 497–502, 2016. View at Publisher · View at Google Scholar
  • Stephen C. Bondy, “Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer's disease and age-related neurodegeneration,” NeuroToxicology, vol. 52, pp. 222–229, 2016. View at Publisher · View at Google Scholar
  • Sandeep Kumar Singh, Saurabh Srivastav, Amarish Kumar Yadav, Saripella Srikrishna, and George Perry, “ Overview of Alzheimer’s Disease and Some Therapeutic Approaches Targeting A β by Using Several Synthetic and Herbal Compounds ,” Oxidative Medicine and Cellular Longevity, vol. 2016, pp. 1–22, 2016. View at Publisher · View at Google Scholar
  • Joana S. Cristóvão, Renata Santos, and Cláudio M. Gomes, “Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease,” Oxidative Medicine and Cellular Longevity, vol. 2016, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • N. Suganthy, and K. Pandima Devi, “In vitro antioxidant and anti-cholinesterase activities of Rhizophora mucronata,” Pharmaceutical Biology, vol. 54, no. 1, pp. 118–129, 2016. View at Publisher · View at Google Scholar
  • Priyanka Chanana, and Anil Kumar, “ Possible Involvement of Nitric Oxide Modulatory Mechanisms in the Neuroprotective Effect of Centella asiatica Against Sleep Deprivation Induced Anxiety Like Behaviour, Oxidative Damage and Neuroinflammation ,” Phytotherapy Research, 2016. View at Publisher · View at Google Scholar
  • Isaac Corbacho, Francisco F. García-Prieto, Ara E. Hinojosa, María Berrocal, and Ana M. Mata, “An improved method for expression and purification of functional human Ca2+ transporter PMCA4b in Saccharomyces cerevisiae,” Protein Expression and Purification, vol. 120, pp. 51–58, 2016. View at Publisher · View at Google Scholar
  • Soo Min Cho, Sejin Lee, Seung-Hoon Yang, Hye Yun Kim, Michael Jisoo Lee, Hyunjin Vincent Kim, Jiyoon Kim, Seungyeop Baek, Jin Yun, Dohee Kim, Yun Kyung Kim, Yakdol Cho, Jiwan Woo, Tae Song Kim, and YoungSoo Kim, “Age-dependent inverse correlations in CSF and plasma amyloid-β(1–42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice,” Scientific Reports, vol. 6, pp. 20185, 2016. View at Publisher · View at Google Scholar
  • Axel Mühlbacher, F. Reed Johnson, Jui-Chen Yang, Michael Happich, and Mark Belger, “Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer’s Disease,” Value in Health, 2016. View at Publisher · View at Google Scholar
  • Luca Guerrini, Raul Arenal, Benedetta Mannini, Fabrizio Chiti, Roberto Pini, Paolo Matteini, and Ramon A. Alvarez-Puebla, “SERS Detection of Amyloid Oligomers on Metallorganic-Decorated Plasmonic Beads,” Acs Applied Materials & Interfaces, vol. 7, no. 18, pp. 9420–9428, 2015. View at Publisher · View at Google Scholar
  • Steven H. Liang, Jason P. Holland, Nickeisha A. Stephenson, Alina Kassenbrock, Benjamin H. Rotstein, Cory P. Daignault, Rebecca Lewis, Lee Collier, Jacob M. Hooker, and Neil Vasdev, “PET Neuroimaging Studies of [F-18]CABS13 in a Double Transgenic Mouse Model of Alzheimer's Disease and Nonhuman Primates,” Acs Chemical Neuroscience, vol. 6, no. 4, pp. 535–541, 2015. View at Publisher · View at Google Scholar
  • B. Muthuraj, Sourav Layek, S. N. Balaji, Vishal Trivedi, and Parameswar Krishnan Iyer, “Multiple Function Fluorescein Probe Performs Metal Chelation, Disaggregation, and Modulation of Aggregated Aβ and Aβ-Cu Complex,” ACS Chemical Neuroscience, pp. 150914082400002, 2015. View at Publisher · View at Google Scholar
  • Diego Mastroeni, Omar M. Khdour, Pablo M. Arce, Sidney M. Hecht, and Paul D. Coleman, “Novel Antioxidants Protect Mitochondria from the Effects of Oligomeric Amyloid Beta and Contribute to the Maintenance of Epigenome Function,” ACS Chemical Neuroscience, pp. 150224135521009, 2015. View at Publisher · View at Google Scholar
  • Federica Prati, Angela De Simone, Andrea Armirotti, Maria Summa, Daniela Pizzirani, Rita Scarpelli, Sine Mandrup Bertozzi, Daniel I. Perez, Vincenza Andrisano, Ana Perez-Castillo, Barbara Monti, Francesca Massenzio, Letizia Polito, Marco Racchi, Piera Sabatino, Giovanni Bottegoni, Ana Martinez, Andrea Cavalli, and Maria L. Bolognesi, “ 3,4-Dihydro-1,3,5-triazin-2(1 H )-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease ,” ACS Chemical Neuroscience, pp. 150803145958007, 2015. View at Publisher · View at Google Scholar
  • Martin Pettersson, Douglas S. Johnson, John M. Humphrey, Todd W. Butler, Christopher W. Am Ende, Benjamin A. Fish, Michael E. Green, Gregory W. Kauffman, Patrick B. Mullins, Christopher J. O'Donnell, Antonia F. Stepan, Cory M. Stiff, Chakrapani Subramanyam, Tuan P. Tran, Beth Cooper Vetelino, Eddie Yang, Longfei Xie, Kelly R. Bales, Leslie R. Pustilnik, Stefanus J. Steyn, Kathleen M. Wood, and Patrick R. Verhoest, “Design of Pyridopyrazine-1,6-dione gamma-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability,” Acs Medicinal Chemistry Letters, vol. 6, no. 5, pp. 596–601, 2015. View at Publisher · View at Google Scholar
  • Steven H. Liang, Adam G. Southon, Benjamin H. Fraser, Anwen M. Krause-Heuer, Bo Zhang, Timothy M. Shoup, Rebecca Lewis, Irene Volitakis, Yifeng Han, Ivan Greguric, Ashley I. Bush, and Neil Vasdev, “Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer’s Disease,” ACS Medicinal Chemistry Letters, pp. 150814140104004, 2015. View at Publisher · View at Google Scholar
  • Lucie A. G. van Leeuwen, and Jeroen J. M. Hoozemans, “Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease,” Acta Neuropathologica, 2015. View at Publisher · View at Google Scholar
  • Kun-mu Zheng, Jing Zhang, Cui-lin Zhang, Yun-wu Zhang, and Xiao-chun Chen, “Curcumin inhibits appoptosin-induced apoptosis via upregulating heme oxygenase-1 expression in SH-SY5Y cells,” Acta Pharmacologica Sinica, vol. 36, no. 5, pp. 544–552, 2015. View at Publisher · View at Google Scholar
  • Fayroz F. Sherif, Nourhan Zayed, and Mahmoud Fakhr, “Discovering Alzheimer Genetic Biomarkers Using Bayesian Networks,” Advances in Bioinformatics, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Gui-Hai Chen, Jing-Jing Tong, Fang Wang, Xue-Qin Hu, Xue-Wei Li, Fei Tao, and Zhao-Jun Wei, “Chronic adjunction of 1-deoxynojirimycin protects from age-related behavioral and biochemical changes in the SAMP8 mice,” Age, vol. 37, no. 5, 2015. View at Publisher · View at Google Scholar
  • Angela L. Jefferson, Alexa S. Beiser, Sudha Seshadri, Philip A. Wolf, and Rhoda Au, “APOE and mild cognitive impairment: the Framingham Heart Study,” Age And Ageing, vol. 44, no. 2, pp. 307–311, 2015. View at Publisher · View at Google Scholar
  • Almira Osmanovic-Thunstrom, Enrico Mossello, Torbjorn Akerstedt, Laura Fratiglioni, and Hui-Xin Wang, “Do levels of perceived stress increase with increasing age after age 65? A population-based study,” Age And Ageing, vol. 44, no. 5, pp. 828–834, 2015. View at Publisher · View at Google Scholar
  • Sukhleen Kour, and Pramod C. Rath, “Long noncoding RNAs in aging and age-related diseases,” Ageing Research Reviews, 2015. View at Publisher · View at Google Scholar
  • William E. Mansbach, Ryan A. Mace, and Kristen M. Clark, “Mild cognitive impairment (MCI) in long-term care patients: subtype classification and occurrence,” Aging & Mental Health, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Yura Lee, and Iris Chi, “Do cognitive leisure activities really matter in the relationship between education and cognition? Evidence from the aging, demographics, and memory study (ADAMS),” Aging & Mental Health, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Géraud Dautzenberg, Luuk Lans, Paul D. Meesters, Ralph Kupka, Aartjan Beekman, Max L. Stek, and Annemiek Dols, “The care needs of older patients with bipolar disorder,” Aging & Mental Health, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Rosario Iodice, Juan José G. Meilán, and Juan Carro, “Improvement of encoding and retrieval in normal and pathological aging with word–picture paradigm,” Aging & Mental Health, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Sasanka Chakrabarti, Vineet Kumar Khemka, Anindita Banerjee, Gargi Chatterjee, Anirban Ganguly, and Atanu Biswas, “Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment,” Aging and Disease, vol. 6, no. 4, pp. 282, 2015. View at Publisher · View at Google Scholar
  • João M N. Duarte, “Metabolic Alterations Associated to Brain Dysfunction in Diabetes,” Aging and Disease, vol. 6, no. 5, pp. 304, 2015. View at Publisher · View at Google Scholar
  • Gargi Chatterjee, Debashree Roy, Vineet Kumar Khemka, Mrittika Chattopadhyay, and Sasanka Chakrabarti*, “Genistein, the Isoflavone in Soybean, Causes Amyloid Beta Peptide Accumulation in Human Neuroblastoma Cell Line: Implications in Alzheimer’s Disease,” Aging and Disease, vol. 6, no. 6, pp. 456, 2015. View at Publisher · View at Google Scholar
  • Heather R. Bailey, Jesse Q. Sargent, Shaney Flores, Petra Nowotny, Alison Goate, and Jeffrey M. Zacks, “ APOE ε4 genotype predicts memory for everyday activities ,” Aging, Neuropsychology, and Cognition, pp. 1–28, 2015. View at Publisher · View at Google Scholar
  • Jorge Alí-Torres, Andrea Mirats, Jean-Didier Maréchal, Luis Rodríguez-Santiago, and Mariona Sodupe, “Modeling Cu2+-Aβ complexes from computational approaches,” AIP Advances, vol. 5, no. 9, pp. 092402, 2015. View at Publisher · View at Google Scholar
  • Li Liang, and Huafeng Wei, “Dantrolene, A Treatment for Alzheimer Disease?,” Alzheimer Disease & Associated Disorders, vol. 29, no. 1, pp. 1–5, 2015. View at Publisher · View at Google Scholar
  • Li Liu, Ke Zhang, Liang Tan, Yu-Hua Chen, and Yun-Peng Cao, “Alterations in Cholesterol and Ganglioside GM1 Content of Lipid Rafts in Platelets From Patients With Alzheimer Disease,” Alzheimer Disease & Associated Disorders, vol. 29, no. 1, pp. 63–69, 2015. View at Publisher · View at Google Scholar
  • Fabio A. Barbieri, Lucas Simieli, Diego Orcioli-Silva, Rodrigo Vitorio, Florindo Stella, and Lilian T. Bucken Gobbi, “Variability in Obstacle Clearance May (Not) Indicate Cognitive Disorders in Alzheimer Disease,” Alzheimer Disease & Associated Disorders, vol. 29, no. 4, pp. 307–311, 2015. View at Publisher · View at Google Scholar
  • Ann De Vos, Dirk Jacobs, Hanne Struyfs, Erik Fransen, Kerstin Andersson, Erik Portelius, Ulf Andreasson, Didier De Surgeloose, Danielle Hernalsteen, Kristel Sleegers, Caroline Robberecht, Christine Van Broeckhoven, Henrik Zetterberg, Kaj Blennow, Sebastiaan Engelborghs, and Eugeen Vanmechelen, “C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease,” Alzheimers & Dementia, vol. 11, no. 12, pp. 1461–1469, 2015. View at Publisher · View at Google Scholar
  • James A. Hendrix, Brad Finger, Michael W. Weiner, Giovanni B. Frisoni, Takeshi Iwatsubo, Christopher C. Rowe, Seong Yoon Kim, Salvador M. Guinjoan, Gustavo Sevlever, and Maria C. Carrillo, “The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update,” Alzheimers & Dementia, vol. 11, no. 7, pp. 850–859, 2015. View at Publisher · View at Google Scholar
  • Mary T. Newport, Theodore B. VanItallie, Yoshihiro Kashiwaya, Michael Todd King, and Richard L. Veech, “A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease,” Alzheimers & Dementia, vol. 11, no. 1, pp. 99–103, 2015. View at Publisher · View at Google Scholar
  • Marina Diomedi, and Alessandro Stefani, “Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF A beta 1-42 combined with neuroimaging biomarkers i,” Alzheimers & Dementia, vol. 11, no. 9, pp. 1123–1124, 2015. View at Publisher · View at Google Scholar
  • Vincent Chouraki, Alexa Beiser, Linda Younkin, Sarah Rosner Preis, Galit Weinstein, Oskar Hansson, Ingmar Skoog, Jean-Charles Lambert, Rhoda Au, Lenore Launer, Philip A. Wolf, Steven Younkin, and Sudha Seshadri, “Plasma amyloid-beta and risk of Alzheimer's disease in the Framingham Heart Study,” Alzheimers & Dementia, vol. 11, no. 3, pp. 249–257, 2015. View at Publisher · View at Google Scholar
  • Michael G. Agadjanyan, Nikolai Petrovsky, and Anahit Ghochikyan, “A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease,” Alzheimers & Dementia, vol. 11, no. 10, pp. 1246–1259, 2015. View at Publisher · View at Google Scholar
  • Michael Ewers, Niklas Mattsson, Lennart Minthon, Jose L. Molinuevo, Anna Antonell, Julius Popp, Frank Jessen, Sanna-Kaisa Herukka, Hilka Soininen, Walter Maetzler, Thomas Leyhe, Katharina Buerger, Miyako Taniguchi, Katsuya Urakami, Simone Lista, Bruno Dubois, Kaj Blennow, and Harald Hampel, “CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study,” Alzheimers & Dementia, vol. 11, no. 11, pp. 1306–1315, 2015. View at Publisher · View at Google Scholar
  • Ron L. H. Handels, Manuela A. Joore, An Tran-Duy, Anders Wimo, Claire A. G. Wolfs, Frans R. J. Verhey, and Johan L. Severens, “Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment de,” Alzheimers & Dementia, vol. 11, no. 8, pp. 896–905, 2015. View at Publisher · View at Google Scholar
  • Ann Hake, Paula T. Trzepacz, Shufang Wang, Peng Yu, Michael Case, Helen Hochstetler, Michael M. Witte, Elisabeth K. Degenhardt, and Robert A. Dean, “Florbetapir positron emission tomography and cerebrospinal fluid biomarkers,” Alzheimer's & Dementia, 2015. View at Publisher · View at Google Scholar
  • Tobias Bittner, Henrik Zetterberg, Charlotte E. Teunissen, Richard E. Ostlund, Michael Militello, Ulf Andreasson, Isabelle Hubeek, David Gibson, David C. Chu, Udo Eichenlaub, Peter Heiss, Uwe Kobold, Andreas Leinenbach, Kairat Madin, Ekaterina Manuilova, Christina Rabe, and Kaj Blennow, “Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid,” Alzheimer's & Dementia, 2015. View at Publisher · View at Google Scholar
  • Michael W. Weiner, Dallas P. Veitch, Paul S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Jesse Cedarbaum, Robert C. Green, Danielle Harvey, Clifford R. Jack, William Jagust, Johan Luthman, John C. Morris, Ronald C. Petersen, Andrew J. Saykin, Leslie Shaw, Li Shen, Adam Schwarz, Arthur W. Toga, and John Q. Trojanowski, “2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception,” Alzheimer's & Dementia, vol. 11, no. 6, pp. e1–e120, 2015. View at Publisher · View at Google Scholar
  • Marco Cecchi, Dennis Moore, Carl Sadowsky, Paul Solomon, P. Murali Doraiswamy, Charles Smith, Gregory Jicha, Andrew E. Budson, Steven Arnold, and K.C. Fadem, “A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings,” Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2015. View at Publisher · View at Google Scholar
  • Sharon J. Sha, Pia M. Ghosh, Suzee E. Lee, Chiara Corbetta-Rastelli, Willian J. Jagust, John Kornak, Katherine P. Rankin, Lea T. Grinberg, Harry V. Vinters, Mario F. Mendez, Dennis W. Dickson, William W. Seeley, Marilu Gorno-Tempini, Joel Kramer, Bruce L. Miller, Adam L. Boxer, and Gil D. Rabinovici, “Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emissi,” Alzheimers Research & Therapy, vol. 7, 2015. View at Publisher · View at Google Scholar
  • Douglas G. Walker, and Lih-Fen Lue, “Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains,” Alzheimers Research & Therapy, vol. 7, 2015. View at Publisher · View at Google Scholar
  • D. V. Moretti, “Conversion of mild cognitive impairment patients in Alzheimer’s disease: prognostic value of Alpha3/Alpha2 electroencephalographic rhythms power ratio,” Alzheimer's Research & Therapy, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  • Charles Kerbage, Carl H. Sadowsky, Pierre N. Tariot, Marc Agronin, Gustavo Alva, F. Darell Turner, Dennis Nilan, Anne Cameron, Gerald D. Cagle, and Paul D. Hartung, “Detection of Amyloid beta Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer's Disease,” American Journal Of Alzheimers Disease And Other Dementias, vol. 30, no. 8, pp. 738–745, 2015. View at Publisher · View at Google Scholar
  • Yongjian Zhu, Zhilong Chen, Xugang Chen, and Sheng Hu, “Serum sEPCR Levels Are Elevated in Patients With Alzheimer's Disease,” American Journal Of Alzheimers Disease And Other Dementias, vol. 30, no. 5, pp. 517–521, 2015. View at Publisher · View at Google Scholar
  • Stavros J. Baloyannis, Ioannis Mavroudis, Demetrios Mitilineos, Ioannis S. Baloyannis, and Vassiliki G. Costa, “The Hypothalamus in Alzheimer's Disease: A Golgi and Electron Microscope Study,” American Journal Of Alzheimers Disease And Other Dementias, vol. 30, no. 5, pp. 478–487, 2015. View at Publisher · View at Google Scholar
  • V. Moro, M. T. Condoleo, V. Valbusa, E. Broggio, G. Moretto, and G. Gambina, “Cognitive Stimulation of Executive Functions in Mild Cognitive Impairment: Specific Efficacy and Impact in Memory,” American Journal Of Alzheimers Disease And Other Dementias, vol. 30, no. 2, pp. 153–164, 2015. View at Publisher · View at Google Scholar
  • Zhangsuo Liu, and Rujun Gong, “Remote Ischemic Preconditioning for Kidney Protection: GSK3 beta-Centric Insights Into the Mechanism of Action,” American Journal Of Kidney Diseases, vol. 66, no. 5, pp. 846–856, 2015. View at Publisher · View at Google Scholar
  • Anta Ngkelo, Roland F. Hoffmann, Andrew L. Durham, John A. Marwick, Simone M. Brandenburg, Harold G. de Bruin, Marnix R. Jonker, Christos Rossios, Eleni Tsitsiou, Gaetano Caramori, Marco Contoli, Paolo Casolari, Francesco Monaco, Filippo Ando, Giuseppe Speciale, Iain Kilty, Kian F. Chung, Alberto Papi, Mark A. Lindsay, Nick H. T. ten Hacken, Maarten van den Berge, Wim Timens, Peter J. Barnes, Antoon J. van Oosterhout, Ian M. Adcock, Paul A. Kirkham, and Irene H. Heijink, “Glycogen synthase kinase-3 beta modulation of glucocorticoid responsiveness in COPD,” American Journal Of Physiology-Lung Cellular And Molecular Physiology, vol. 309, no. 10, pp. L1112–L1123, 2015. View at Publisher · View at Google Scholar
  • Claudia Cooper, Andrew Sommerlad, Constantine G. Lyketsos, and Gill Livingston, “Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis,” American Journal Of Psychiatry, vol. 172, no. 4, pp. 323–334, 2015. View at Publisher · View at Google Scholar
  • Kenji Sasahara, Kenichi Morigaki, and Yasuko Mori, “Uptake of raft components into amyloid β-peptide aggregates and membrane damage,” Analytical Biochemistry, 2015. View at Publisher · View at Google Scholar
  • Tina B. Angerer, Masoumeh Dowlatshahi Pour, Per Malmberg, and John S. Fletcher, “Improved Molecular Imaging in Rodent Brain with Time-of-Flight-Secondary Ion Mass Spectrometry Using Gas Cluster Ion Beams and Reactive Vapor Exposure,” Analytical Chemistry, pp. 150402134236006, 2015. View at Publisher · View at Google Scholar
  • Robert Root-Bernstein, “How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Syner,” Anti-Cancer Agents In Medicinal Chemistry, vol. 15, no. 10, pp. 1242–1259, 2015. View at Publisher · View at Google Scholar
  • Carlotta Giorgi, Sonia Missiroli, Simone Patergnani, Jerzy Duszynski, Mariusz R. Wieckowski, and Paolo Pinton, “Mitochondria-Associated Membranes: Composition, Molecular Mechanisms, and Physiopathological Implications,” Antioxidants & Redox Signaling, pp. 150313135409006, 2015. View at Publisher · View at Google Scholar
  • Mohamed Salama, and Wael M.Y. Mohamed, “NDUFA12L mitochondrial complex-I assembly factor: Implications for tauopathies,” Applied & Translational Genomics, 2015. View at Publisher · View at Google Scholar
  • Sina Shadfar, Chul Ju Hwang, Mi-Sun Lim, Dong-Young Choi, and Jin Tae Hong, “Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents,” Archives of Pharmacal Research, 2015. View at Publisher · View at Google Scholar
  • Dong-Young Choi, and Hyukjae Choi, “Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischem,” Archives Of Pharmacal Research, vol. 38, no. 2, pp. 139–170, 2015. View at Publisher · View at Google Scholar
  • Giuseppe Paradies, Valeria Paradies, Francesca M. Ruggiero, and Giuseppe Petrosillo, “Protective role of melatonin in mitochondrial dysfunction and related disorders,” Archives Of Toxicology, vol. 89, no. 6, pp. 923–939, 2015. View at Publisher · View at Google Scholar
  • Eun Kyung Kim, and Eui-Ju Choi, “Compromised MAPK signaling in human diseases: an update,” Archives of Toxicology, 2015. View at Publisher · View at Google Scholar
  • Bianca Torres, Raquel Luiza Santos, Maria Fernanda Barroso de Sousa, Jose Pedro Simoes Neto, Marcela Moreira Lima Nogueira, Tatiana T. Belfort, Rachel Dias, and Marcia Cristina Nascimento Dourado, “Facial expression recognition in Alzheimer's disease: a longitudinal study,” Arquivos De Neuro-Psiquiatria, vol. 73, no. 5, pp. 383–389, 2015. View at Publisher · View at Google Scholar
  • Jing-Jing Tong, Gui-Hai Chen, Fang Wang, Xue-Wei Li, Lei Cao, Xu Sui, Fei Tao, Wen-Wen Yan, and Zhao-Jun Wei, “Chronic acarbose treatment alleviates age-related behavioral and biochemical changes in SAMP8 mice,” Behavioural Brain Research, vol. 284, pp. 138–152, 2015. View at Publisher · View at Google Scholar
  • Jin Gao, He He, Wenjiao Jiang, Xiayun Chang, Lingpeng Zhu, Fen Luo, Rui Zhou, Chunhua Ma, and Tianhua Yan, “Salidroside ameliorates cognitive impairment in a d-galactose-induced rat model of Alzheimer’s disease,” Behavioural Brain Research, vol. 293, pp. 27–33, 2015. View at Publisher · View at Google Scholar
  • Pengcheng Huang, Cai Li, Tianli Fu, Dan Zhao, Zhen Yi, Qing Lu, Lianjun Guo, and Xulin Xu, “Flupirtine attenuates chronic restraint stress-induced cognitive deficits and hippocampal apoptosis in male mice,” Behavioural Brain Research, vol. 288, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Xing Chen, Feng Long, Bin Cai, Xiaohong Chen, and Gang Chen, “A novel relationship for schizophrenia, bipolar and major depressive disorder Part 7: a hint from chromosome 7 high density association screen,” Behavioural Brain Research, 2015. View at Publisher · View at Google Scholar
  • Hui-Yun Yang, Yang Liu, Jia-Cun Xie, Nan-Nan Liu, and Xin Tian, “Effects of repetitive transcranial magnetic stimulation on synaptic plasticity and apoptosis in vascular dementia rats,” Behavioural Brain Research, vol. 281, pp. 149–155, 2015. View at Publisher · View at Google Scholar
  • Ying Zeng, and Ke Yang, “Sirtuin 1 participates in the process of age-related retinal degeneration,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Clare Stretton, Thorsten M. Hoffmann, Michael J. Munson, Alan Prescott, Peter M. Taylor, Ian G. Ganley, and Harinder S. Hundal, “GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling,” Biochemical Journal, vol. 470, pp. 207–221, 2015. View at Publisher · View at Google Scholar
  • Mingzhan Xue, Hiroshi Momiji, Naila Rabbani, Till Bretschneider, David A. Rand, and Paul J. Thornalley, “Frequency modulated translocational oscillations of Nrf2, a transcription factor functioning like a wireless sensor,” Biochemical Society Transactions, vol. 43, pp. 669–673, 2015. View at Publisher · View at Google Scholar
  • Jose O. Esteves-Villanueva, Hanna Trzeciakiewicz, David A. Loeffler, and Sanela Martic, “Effects of Tau Domain-Specific Antibodies and Intravenous lmmunoglobulin on Tau Aggregation and Aggregate Degradation,” Biochemistry, vol. 54, no. 2, pp. 293–302, 2015. View at Publisher · View at Google Scholar
  • Sandra I. Mota, Rui O. Costa, Ildete L. Ferreira, Isabel Santana, Gladys L. Caldeira, Carmela Padovano, Ana C. Fonseca, Inês Baldeiras, Catarina Cunha, Liliana Letra, Catarina R. Oliveira, Cláudia M.F. Pereira, and Ana Cristina Rego, “Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer’s disease,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015. View at Publisher · View at Google Scholar